Australia TGA ARTG record

Arrythmia-detection sphygmomanometer

Australia TGA ARTG Registered Device · Wymedical Pty Ltd · Microlife Corporation · Class IIa · Started November 01, 2023

Good Name: Wymedical Pty Ltd - Arrythmia-detection sphygmomanometer

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: November 01, 2023
Effective Date: November 01, 2023

Sponsor

Name: Wymedical Pty Ltd

Manufacturer

Name: Microlife Corporation
Country: Taiwan
Address: 9F 431 RuiGuang Road, Nei Hu, Taipei, 11492

Intended purpose

Intended for measuring non-invasive blood pressure and can detect an irregular pulse suggestive of Atrial Fibrillation. It can be used in patients such as those with hypertension, hypotension, diabetes, pregnancy, pre-eclampsia, atherosclerosis, end-stage renal disease, obesity and in the elderly.

About this record

Access comprehensive regulatory information for Arrythmia-detection sphygmomanometer in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Wymedical Pty Ltd, manufactured by Microlife Corporation in Taiwan. The device registration started on November 01, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.